Home

Exosomes

Instead of layering multiple products, providers get a single exosome-based human biologic that fits directly into current services.

EXOSOME
Derived from human amniotic fluid (PSF-003)
  • 35 Billion Exosomes
  • Natural Human α-Klotho
  • Biologically active cytokines
  • RNAs, mRNAs
  • Natural human hyaluronic acid
  • Chondroitin sulfate
  • 300+ Growth Factors
  • Full Lot & Donor Traceability
Exosome vial — 35 billion exosomes with natural human α-Klotho from amniotic fluid

How It Works

Mechanism of Action

Naturally present in ethically sourced donor amniotic fluid, exosomes are isolated and purified into PSF-003, a ready-to-use, cell-free human biologic. Once administered, exosomes bind to target cells and deliver their molecular cargo, providing the body with essential signals present in young tissue but often diminished with age, supporting its natural healing process without introducing live cells.

For providers, that means Exosomes work in synergy with existing services, layered into treatments like microneedling, CO2, fractional, plasma, or PRP protocols to soothe and enhance the results patients already expect. Because PSF-003 arrives pre-processed and ready to administer, it adds to a service menu without the onsite processing, live-cell handling, or added chair time that comes with therapies like PRP, making it as much a replacement for labor-intensive protocols as it is an enhancement to existing ones.

Testing & Safety

Facility
FDA Registered (FEI# 3017371366). Also inspected by Florida Dept. of Business & Professional Regulation, Division of Drugs, Devices & Cosmetics.
Manufacturing Standard
Current Good Manufacturing Practice (cGMP)
Testing
Fully tested by an independent, third-party, CLIA-certified laboratory
Exosome Identity Testing
Tested for expression of Tetraspanins (CD9, CD86, CD81) — markers used to confirm exosome identity
Donor Eligibility
All birth tissue donors screened for eligibility per AATB and FDA standards
Source Tissue
Human Amniotic Fluid (PSF-003), collected by US recovery agencies
Processing
Proprietary processing techniques adhering to AATB and FDA standards
Active Components
α-Klotho, Hyaluronic Acid, Chondroitin Sulfate, RNAs & mRNAs, 300+ Growth Factors & Cytokines
Traceability
Full lot/donor per vial

Clinical Applications

Aesthetics

Skin rejuvenation, microneedling enhancement, and facial restoration protocols leveraging exosome signaling for collagen synthesis and tissue renewal.

Hair Restoration

Targeted scalp treatments combining exosomes with PRP or standalone protocols to support follicle health and hair growth cycles.

Orthopedic

Joint, tendon, and ligament support through localized exosome delivery to modulate inflammation and promote connective tissue repair.

Wound Healing

Accelerated tissue repair for chronic and acute wounds through exosome-mediated cellular signaling and angiogenesis support.

Sexual Health

Regenerative protocols for sexual wellness applications, leveraging growth factor delivery for tissue revitalization.

Dental

Oral surgery recovery, implant site preparation, and periodontal tissue support through targeted exosome application.

Donor Infectious Disease Screening (11-Panel)

01

CMV Total Antibody

02

HBV Core Antibody (Hepatitis B Virus)

03

Hepatitis B Surface Antigen

04

Syphilis Screening (Non-treponemal)

05

HBV NAT/PCR

06

HTLV (Types I and II)

07

HCV Encoded Antigens (Hepatitis C Virus)

08

WNV (West Nile Virus)

09

HCV NAT/PCR

10

HIV (Types 1 & 2, plus O)

11

HIV-1/2 NAT/PCR

All testing is performed according to CDC, FDA, and US Organ Procurement and Transplantation Network policies. Donors are rejected for any reactive, positive, or equivocal result and accepted only when results are nonreactive, negative, or non-equivocal.

Compliance & Regulatory

FDA Registered (FEI# 3017371366) — laboratory partner
Florida DBPR, Division of Drugs, Devices & Cosmetics — facility inspected
cGMP
Third-Party CLIA-Certified Lab Testing
Full Lot & Donor Traceability
All products are processed and distributed by independently owned and operated FDA-registered laboratory partners. Sōlix does not manufacture, compound, or take possession of any biological product. Products are minimally manipulated human cells, tissues, and cellular and tissue-based products (HCT/Ps) regulated under 21 CFR Part 1271, intended for homologous use only. Administration is at the sole discretion of a licensed healthcare provider. The statements on this page have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
Explore More Products
Wharton's JellyStem CellsMuse CellsCompare All Products

Partner with us.

Whether you run a med spa, surgical suite, clinical practice, or wellness center. Sōlix gives you the science, the support, and the platform to offer your patients something better.

Built by AUSTAN

DISCLAIMER

Sōlix does not own, operate, or manage any laboratory, manufacturing, or compounding facility. All biological products available through this platform are manufactured, processed, and distributed by our independently owned and operated FDA-registered laboratory partners. Sōlix does not distribute, ship, handle, or take possession of any biological product at any point in the supply chain.

Sōlix operates as a provider platform that offers licensed healthcare practitioners access to product ordering, clinical education, implementation support, marketing resources, and business integration tools designed to help practices incorporate regenerative biologics into their clinical offerings.

Sōlix is not a compounding pharmacy or chemical compounding facility as defined under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. Sōlix does not compound, manufacture, repackage, or relabel any drug or biological product.

Sōlix resources are for educational and informational purposes only. Providers are responsible for their own regulatory compliance, licensing, and insurance. Sōlix assumes no liability for how materials are applied in practice.

FDA DISCLAIMER

The statements made on this website have not been evaluated by the U.S. Food and Drug Administration. The products and services referenced on this platform are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Biological products, including but not limited to stem cells, exosomes, Wharton's Jelly, and amniotic tissue allografts, are minimally manipulated human cells, tissues, and cellular and tissue-based products (HCT/Ps) regulated under 21 CFR Part 1271. These products are intended for homologous use only and are administered at the sole discretion of a licensed healthcare provider following individual patient assessment. Results may vary. No guarantees of specific outcomes are made or implied.

All medical decisions, including the use of regenerative biologics, should be made in consultation with a qualified healthcare professional. Sōlix makes no medical claims and assumes no liability for clinical outcomes resulting from the use of products ordered through this platform.

Sōlix provides a provider platform and sales CRM for ordering regenerative human biologics, managing provider relationships, and integrating third-party services including Google Calendar for scheduling and appointment management. For details on how we handle your data, see our Privacy Policy.

Terms & ConditionsPrivacy Policy